Dr. Lois J. Eldred is an assistant professor of medicine at the Johns Hopkins University School of Medicine. She holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. She received her B.S. from Johns Hopkins and earned both a Dr.P.H. and an M.P.H. at the Johns Hopkins Bloomberg School of Public Health. Dr. Eldred’s research focuses on infectious diseases, including HIV/AIDS, hepatitis C and tuberculosis. She is senior manager for the Center for AIDS Research Clinical Core and a research associate in General Internal Medicine. M.P.H., Johns Hopkins Bloomberg School of Public Health (Maryland) (1987) DrPH, Johns Hopkins Bloomberg School of Public Health (Maryland) (1997)

Infectious diseases; AIDS; HIV; Hepatitis C; Tuberculosis; Injection drug users

Balagopal A, Kandathil AJ, Higgins YH, Wood J, Richer J, Quinn J, Eldred L, Li Z, Ray SC, Sulkowski MS, Thomas DL. "Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients." Hepatology. 2014 Aug;60(2):477-86. doi: 10.1002/hep.27158 Kass NE, DeLuca AN, Coetzee L, Simwinga M, Churchyard GJ, Ayles H, Beyers N, Godfrey-Faussett P, Durovni B, Chaisson RE, Eldred LJ. "Applying ethical principles to international community-based research: a case study from the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE)." IRB. 2014 May-Jun;36(3):1-8 Saraceni V, Pacheco AG, Golub JE, Vellozo V, King BS, Cavalcante SC, Eldred L, Chaisson RE, Durovni B. "Physician adherence to guidelines for tuberculosis and HIV care in Rio de Janeiro, Brazil." Braz J Infect Dis. 2011 May-Jun;15(3):249-52 Eldred LJ, Churchyard G, Durovni B, Godfrey-Faussett P, Grant AD, Getahun H, Chaisson RE. "Isoniazid preventive therapy for HIV-infected people: evidence to support implementation." AIDS. 2010 Nov;24 Suppl 5:S1-3. doi: 10.1097/01.aids.0000391009.95149.ec Knowlton AR, Arnsten JH, Eldred LJ, Wilkinson JD, Shade SB, Bohnert AS, Yang C, Wissow LS, Purcell DW. "Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors." AIDS Patient Care STDS. 2010 Jul;24(7):421-8. doi: 10.1089/apc.2009.0240